An interventional study of Intrathecal Morphine and Intrathecal Dexmedetomidine in Intrathecal Morphine, Intrathecal Dexmedetomidine and Placebo, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-20.
Sponsored by Tanta University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies testing morphine in Pain, Postoperative — 17 open to participants now, 20 under way, 1 of them phase 3. Morphine · Pain, Postoperative.
Among the 96 studies testing morphine in Pain, Postoperative, this one is the 41st largest by planned enrollment, is one of 5 that started in 2026, is one of 34 with no phase, reaches primary completion later than 18 of the 19 other live ones, and was the 93rd registered.
5,654 studies on the registry are indexed under Pain, Postoperative; 1,233 are open to participants now.
Browse Pain, Postoperative studies →17 of the 96 studies testing morphine in Pain, Postoperative are open now, in 11 countries. Recruiting first, the newest first:
Sohag University · Sites in Egypt
Ages 18–60
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 18+
Ataturk University · Sites in Turkey
Ages 18–65 · Women only
Anne Juul Wikkelsø · Sites in Denmark
Ages 18+ · Women only
Meri Mirceta · Sites in Croatia
Ages 18–80
By country, each count listing its studies:
Morphine: first FDA approval 1984 (DURAMORPH PF). What it is approved for, and how studies give it, is on its page →
Of the 676 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 327 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.
This study: 21 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 15 · Phase 3 11 · Phase 4 41
First in 2001; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 75 across 4,835 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 96 interventional studies. Of the 60 that completed or were terminated, 14 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 96 have an industry lead sponsor. The 10 most frequent:
Tanta University is the lead sponsor of 1,013 studies on the registry; 321 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
38 studies in Pain, Postoperative by Tanta University: 7 open now, 8 under way, 1 of them phase 3. Of 26 finished, 0 (0%) have results posted.
Among the 38 studies in Pain, Postoperative by Tanta University, this one is the 6th largest by planned enrollment, is one of 5 that started in 2026, is one of 36 with no phase, and was the 36th registered.
Tanta University’s Pain, Postoperative studies by the year they started, since 2014.
5 of the studies testing morphine in Pain, Postoperative that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07720739Sohag UniversityEfficacy of Adding Intrathecal Morphine to Erector Spinae Plane Block for Postoperative Analgesia After Midline Laparotomy | 2026-11 |
| NCT06761989Seoul National University HospitalIntrathecal Morphine Injection Versus Continuous Wound Infiltration After Pancreaticoduodenectomy | 2026-12-31 |
| NCT06797973Anne Juul WikkelsøEfficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section | 2027-05-31 |
| NCT05351229Northwestern UniversityIntrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery | 2027-06-01 |
| NCT07803133Erzincan Binali Yildirim UniversitesiPENG Block Versus Intrathecal Morphine for Early Postoperative Recovery After Total Hip Arthroplasty | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 96 studies testing morphine in Pain, Postoperative, from their registry updates:
Among Tanta University’s 38 in Pain, Postoperative:
This tab as a report to print or save as PDF → With an account.
This study aims to compare the efficacy of intrathecal morphine and intrathecal dexmedetomidine in reducing pain following lumbar spine fixation surgeries.
Spine surgeries represent a challenge to the anesthetists, as they are accompanied by multiple perioperative problems, including significant intraoperative blood loss and severe postoperative pain.
Morphine is a prototypical opioid analgesic that acts mainly on mu-opioid receptors in the central nervous system. It exerts its analgesic effects by binding to these receptors, inhibiting the release of a neurotransmitter known as substance P, thereby diminishing pain perception.
Dexmedetomidine (DEX) is a highly selective and potent α-2 adrenoceptor agonist. Its intrathecal administration leads to anti-nociceptive effects, although it has some undesired side effects (e.g., hypotension, bradycardia, and sedation).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive intrathecal morphine (0,3 mg) in 2 ml normal saline at the end of the operation through a 25G spinal needle through the lumbar intervertebral space (L3-L4 or L4-L5).
Drug: Intrathecal Morphine
Patients will receive intrathecal dexmedetomidine (8mcg) in 2 ml normal saline at the end of the operation through a 25G spinal needle through the lumbar intervertebral space (L3-L4 or L4-L5).
Drug: Intrathecal Dexmedetomidine
Patients will receive intrathecal 2 ml normal saline at the end of the operation through a 25G spinal needle through the lumbar intervertebral space (L3-L4 or L4-L5).
Drug: Normal Saline
Patients will receive intrathecal morphine (0,3 mg) in 2 ml normal saline at the end of the operation through a 25G spinal needle through the lumbar intervertebral space (L3-L4 or L4-L5).
Patients will receive intrathecal 2 ml normal saline at the end of the operation through a 25G spinal needle through the lumbar intervertebral space (L3-L4 or L4-L5).
Patients will receive intrathecal 2 ml normal saline at the end of the operation through a 25G spinal needle through the lumbar intervertebral space (L3-L4 or L4-L5).
Time to the first rescue analgesia
Time to the first rescue analgesia will be recorded from the end of surgery till the first dose of pethidine adminstrated.
Time frame: 24 hours postoperatively
Heart rate
Heart rate will be recorded at rest (static) and on movement (dynamic), evaluated at 30 minutes, 1, 2, 4, 8, 12, and 24 h after surgery.
Time frame: 24 hours postoperatively
Mean arterial pressure
Mean arterial pressure will be recorded at rest (static) and on movement (dynamic), evaluated at 30 minutes, 1, 2, 4, 8, 12, and 24 h after surgery.
Time frame: 24 hours postoperatively
Degree of pain
Postoperative pain will be assessed using visual analog scale (VAS) scores where (0 = no pain, 10 = the worst possible pain), postoperative pain will be assessed at rest (static) and on movement (dynamic), evaluated at 30 minutes, 1, 2, 4, 8, 12, and 24 h after surgery
Time frame: 24 hours postoperatively
Postoperative sedation score
The Sedation Scale (modified Observer's Assessment of Alertness/Sedation (OAA/S) scale). (6 = Agitated, 5 = Responds readily to name spoken in normal tone, 4 = Lethargic response to name spoken in normal tone, 3 = Responds only after name is called loudly and/or repeatedly, 2 = Responds only after mild prodding or shaking, 1 = Does not respond to mild prodding or shaking, 0 = Does not respond to deep stimulus)
Time frame: 24 hours postoperatively
Total pethidine consumption
After assessment of pain scores, when visual analog scale (VAS) score measures ≥3, patients will receive 25 mg pethidine, which can be repeated.
Time frame: 24 hours postoperatively
Incidence of adverse effect
Incidence of adverse effect such as pruritus, nausea/vomiting, bradycardia, hypotension, and respiratory depression will be recorded.
Time frame: 24 hours postoperatively
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for Jul 2028, 24 months after the start.
Of 2,097 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 24 months is above that.
Counting every sponsor, half of 2,110 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Morphine · Dexmedetomidine